Cargando…
Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies
We herein report a 61-year-old woman who was genetically diagnosed with spinocerebellar ataxia type 31 whose symptoms were modified by anti-amino terminal of alpha-enolase (NAE) antibodies, known as a biomarker of Hashimoto's encephalopathy (HE), and ultimately responded to immunotherapy. The r...
Autores principales: | Zeniya, Satoshi, Sanjo, Nobuo, Kuwahara, Hiroya, Ishikawa, Kinya, Higashi, Miwa, Matsunaga, Akiko, Yoneda, Makoto, Mizusawa, Hidehiro, Yokota, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556240/ https://www.ncbi.nlm.nih.gov/pubmed/36104177 http://dx.doi.org/10.2169/internalmedicine.8883-21 |
Ejemplares similares
-
Spinocerebellar Ataxia Type 31 with Blepharospasm
por: Itaya, Sakiko, et al.
Publicado: (2018) -
Spinocerebellar ataxia type 31 (SCA31)
por: Ishikawa, Kinya
Publicado: (2022) -
Thymidine Kinase 2 and Mitochondrial Protein COX I in the Cerebellum of Patients with Spinocerebellar Ataxia Type 31 Caused by Penta-nucleotide Repeats (TTCCA)(n)
por: Aoki, Hanako, et al.
Publicado: (2022) -
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31)
por: Ishikawa, Kinya, et al.
Publicado: (2019) -
Insight Into Spinocerebellar Ataxia Type 31 (SCA31) From Drosophila Model
por: Ishiguro, Taro, et al.
Publicado: (2021)